Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Lukas Feil"'
Autor:
Lukas Feil, André Koch, Raphael Utz, Michael Ackermann, Jakob Barz, Matthias Stope, Bernhard Krämer, Diethelm Wallwiener, Sara Y. Brucker, Martin Weiss
Publikováno v:
Cancers, Vol 12, Iss 4, p 1037 (2020)
Cold atmospheric plasma (CAP) treatment is developing as a promising option for local anti-neoplastic treatment of dysplastic lesions and early intraepithelial cancer. Currently, high-frequency electrosurgical argon plasma sources are available and w
Externí odkaz:
https://doaj.org/article/2018eb86eb174f98be1e0e6b654ec578
Autor:
Michael S. Anglesio, Martin Köbel, Stefan Kommoss, Tjalling Bosse, Annette Staebler, Anna V. Tinker, Naveena Singh, Jessica N. McAlpine, Ali Bashashati, Emily F. Thompson, Marco de Bruyn, Hans W. Nijman, Cornelis D. de Kroon, Ranjit Manchanda, Hans-Walter Vollert, Friedrich Kommoss, Sabine Heublein, Hans-Peter Sinn, Felix K.F. Kommoss, Philipp Harter, Andreas du Bois, Florian Heitz, Sara Brucker, Bernhard Krämer, Andreas Hartkopf, Katherine Dixon, Jana Pasternak, Lukas Feil, Samuel Leung, Janine Senz, Zhouchunyang Xia, Marcel Grube, Tayyebeh M. Nazeran, David Farnell, Rory F.L. Hammond, Daniëlla A. Scheunhage, Evan S. Cairns, Derek S. Chiu, Mary Anne Brett, Aline Talhouk, Pauline Krämer
Package with all supplemental figures and tables
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60baa06a33333d8bf732a840579d7f89
https://doi.org/10.1158/1078-0432.22476891
https://doi.org/10.1158/1078-0432.22476891
Autor:
Michael S. Anglesio, Martin Köbel, Stefan Kommoss, Tjalling Bosse, Annette Staebler, Anna V. Tinker, Naveena Singh, Jessica N. McAlpine, Ali Bashashati, Emily F. Thompson, Marco de Bruyn, Hans W. Nijman, Cornelis D. de Kroon, Ranjit Manchanda, Hans-Walter Vollert, Friedrich Kommoss, Sabine Heublein, Hans-Peter Sinn, Felix K.F. Kommoss, Philipp Harter, Andreas du Bois, Florian Heitz, Sara Brucker, Bernhard Krämer, Andreas Hartkopf, Katherine Dixon, Jana Pasternak, Lukas Feil, Samuel Leung, Janine Senz, Zhouchunyang Xia, Marcel Grube, Tayyebeh M. Nazeran, David Farnell, Rory F.L. Hammond, Daniëlla A. Scheunhage, Evan S. Cairns, Derek S. Chiu, Mary Anne Brett, Aline Talhouk, Pauline Krämer
Purpose:Endometrioid ovarian carcinoma (ENOC) is generally associated with a more favorable prognosis compared with other ovarian carcinomas. Nonetheless, current patient treatment continues to follow a “one-size-fits-all” approach. Even though t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14b9aabdfb3919cf5914ae24c00c5d1d
https://doi.org/10.1158/1078-0432.c.6529509.v1
https://doi.org/10.1158/1078-0432.c.6529509.v1
Autor:
Linda E. Kelemen, Lukas Feil, Katharina Wiedemeyer, Sarah Glaze, Shuhong Liu, Young Ou, Gregg Nelson, Linyuan Wang, Eun Young Kang, Michael S. Anglesio, Martin Köbel, Prafull Ghatage
Publikováno v:
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists. 41(2)
In this study, we aimed to test whether prognostic biomarkers can achieve a clinically relevant stratification of patients with stage I ovarian clear cell carcinoma (OCCC) and to survey the expression of 10 selected actionable targets (theranostic bi
Autor:
Sarah Glaze, Linda E. Kelemen, Shuhong Liu, Young Ou, Lukas Feil, Katharina Wiedemeyer, Michael S. Anglesio, Martin Köbel, Linyuan Wang, Prafull Ghatage, Gregg Nelson, Eun Young Kang
SummaryIn this study, we aimed to test whether prognostic biomarkers can achieve a clinically relevant stratification of patients with stage I ovarian clear cell carcinoma (OCCC) and to survey the expression of 10 selected actionable targets (theragn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50c9fe0616b21c91a9cb5dd724f40097
https://doi.org/10.1101/2020.08.21.20178830
https://doi.org/10.1101/2020.08.21.20178830
Autor:
Hans-Peter Sinn, Ali Bashashati, Anna V. Tinker, Hans W. Nijman, Andreas D. Hartkopf, Felix K. F. Kommoss, Florian Heitz, Michael S. Anglesio, Derek S. Chiu, Lukas Feil, Emily F Thompson, Friedrich Kommoss, Mary Anne Brett, Martin Köbel, P Krämer, Aline Talhouk, Katherine Dixon, Bernhard K. Krämer, Sara Y. Brucker, Annette Staebler, Marco de Bruyn, Janine Senz, David Farnell, Naveena Singh, Philipp Harter, Zhouchunyang Xia, Daniëlla A Scheunhage, Tayyebeh M. Nazeran, Rory F L Hammond, M Grube, J Pasternak, H.-W. Vollert, Cornelis D. de Kroon, Sabine Heublein, Jessica N. McAlpine, Stefan Kommoss, Samuel Leung, Tjalling Bosse, Andreas du Bois, Ranjit Manchanda, Evan S. Cairns
Publikováno v:
Clinical Cancer Research, 26(20), 5400-5410. AMER ASSOC CANCER RESEARCH
Purpose: Endometrioid ovarian carcinoma (ENOC) is generally associated with a more favorable prognosis compared with other ovarian carcinomas. Nonetheless, current patient treatment continues to follow a “one-size-fits-all” approach. Even though
Publikováno v:
European Journal of Obstetrics & Gynecology and Reproductive Biology. 234:e131